Eye Health Expansion Occuity’s focus on non-contacting optical devices for eye measurements (pachymeter, axial length, keratometry) and disease screening presents cross-selling opportunities with optometry clinics, ophthalmology practices, and vision care chains looking to modernize screening and monitoring workflows.

Diabetes & Screening With ongoing development to screen for diabetes and pre-diabetes via eye scans and plans to deploy in high street opticians, pharmacies, and care homes, there is a near-term path to partnerships with retail health hubs and managed care providers seeking scalable screening solutions.

Non-Invasive Monitoring The aim to deliver non-invasive, non-contact glucose monitoring and AGEs measurement points to opportunities with endocrinology clinics, diabetes care programs, and aging healthcare systems that require painless, patient-friendly monitoring devices.

Strategic Funding Signals Recent Innovate UK grant funding and recognition as a Hard Tech Investment finalist indicate credibility with investors and potential customers; leverage this to co-create pilot programs, grant-supported deployments, and joint research opportunities with health systems.

Product Roadmap Synergy Launches like PM1 Pachymeter and AX1 Axiometer, plus planned SD1 AGE measurement, create a stacked solution suite for eye measurements and systemic health indicators; target multi-device procurement within clinics, hospital networks, and veterinary optometry practices seeking integrated screening ecosystems.